FARE Clinical Trial Finder

Simplify your search for a clinical trial and help researchers discover new therapies. The FARE Clinical Trial Finder links patients with food allergy and healthy, non-patient volunteers to actively recruiting food allergy studies.

Safety Study of Viaskin Peanut to Treat Peanut Allergy

Study Purpose

This study evaluates the safety of Viaskin Peanut 250 mcg in the treatment of peanut allergy in children from 4 to 11 years of age. Subjects will receive either Viaskin Peanut 250 mcg or a placebo for a period of 6 months, after which all subjects will be receiving the active treatment up to a period of 3 years under active treatment.

Recruitment Criteria

Accepts Healthy Volunteers

Healthy volunteers are participants who do not have a disease or condition, or related conditions or symptoms

No
Study Type

An interventional clinical study is where participants are assigned to receive one or more interventions (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes.


An observational clinical study is where participants identified as belonging to study groups are assessed for biomedical or health outcomes.


Searching Both is inclusive of interventional and observational studies.

Interventional
Eligible Ages 4 Years - 11 Years
Gender All
More Inclusion & Exclusion Criteria

Inclusion Criteria:

  • - Physician-diagnosed peanut allergy; - A peanut Skin Prick Test (SPT) with a wheal largest diameter ≥8 mm; - A specific-peanut Immunoglobulin E (IgE) ≥14 kU/L; - Subjects following a strict peanut-free diet.

Exclusion Criteria:

  • - Generalized dermatologic disease - Spirometry forced expiratory volume in 1 second (FEV1) <80% of the predicted value, or peak expiratory flow (PEF) <80% of predicted value; - Receiving β-blocking agents, angiotensin-converting enzyme inhibitors, angiotensin-receptor blockers, calcium channel blockers or tricyclic antidepressant therapy; anti-tumor necrosis factor drugs or anti-IgE drugs (such as omalizumab) or any biologic immunomodulatory therapy; - Prior or concomitant history of any immunotherapy to any food allergy (for example EPIT, OIT, SLIT, or specific oral tolerance induction).

Trial Details

Trial ID:

This trial id was obtained from ClinicalTrials.gov, a service of the U.S. National Institutes of Health, providing information on publicly and privately supported clinical studies of human participants with locations in all 50 States and in 196 countries.

NCT02916446
Phase

Phase 1: Studies that emphasize safety and how the drug is metabolized and excreted in humans.

Phase 2: Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition) and additional safety data.

Phase 3: Studies that gather more information about safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs.

Phase 4: Studies occurring after FDA has approved a drug for marketing, efficacy, or optimal use.

Phase 3
Lead Sponsor

The sponsor is the organization or person who oversees the clinical study and is responsible for analyzing the study data.

DBV Technologies
Principal Investigator

The person who is responsible for the scientific and technical direction of the entire clinical study.

N/A
Principal Investigator Affiliation N/A
Agency Class

Category of organization(s) involved as sponsor (and collaborator) supporting the trial.

Industry
Overall Status Active, not recruiting
Countries Canada, United States
Conditions

The disease, disorder, syndrome, illness, or injury that is being studied.

Peanut Allergy

Contact a Trial Team

If you are interested in learning more about this trial, find the trial site nearest to your location and contact the site coordinator via email or phone. We also strongly recommend that you consult with your healthcare provider about the trials that may interest you and refer to our terms of service below.

ASTHMA, Inc. Clinical Research, Seattle, Washington

Status

Address

ASTHMA, Inc. Clinical Research

Seattle, Washington, 98115-2060

STAAMP Research, San Antonio, Texas

Status

Address

STAAMP Research

San Antonio, Texas, 78251

Sylvana Research, San Antonio, Texas

Status

Address

Sylvana Research

San Antonio, Texas, 78229

Houston, Texas

Status

Address

Baylor College of Medicine - Texas Children's Hospital

Houston, Texas, 77030

Children's Medical Center of Dallas, Dallas, Texas

Status

Address

Children's Medical Center of Dallas

Dallas, Texas, 75390-9105

National Allergy and Asthma Research, Charleston, South Carolina

Status

Address

National Allergy and Asthma Research

Charleston, South Carolina, 29407

Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania

Status

Address

Children's Hospital of Pittsburgh

Pittsburgh, Pennsylvania, 15213

Children's Hospital of Philadelphia, Philadelphia, Pennsylvania

Status

Address

Children's Hospital of Philadelphia

Philadelphia, Pennsylvania, 19104

Chapel Hill, North Carolina

Status

Address

The University of North Carolina - Chapell Hill

Chapel Hill, North Carolina, 27599

Mount Sinai Medical Center, New York, New York

Status

Address

Mount Sinai Medical Center

New York, New York, 10029

The Asthma and Allergy Center, Bellevue, Nebraska

Status

Address

The Asthma and Allergy Center

Bellevue, Nebraska, 68123

Children's Mercy Hospital, Kansas City, Missouri

Status

Address

Children's Mercy Hospital

Kansas City, Missouri, 64108

Clinical Research Institute, Plymouth, Minnesota

Status

Address

Clinical Research Institute

Plymouth, Minnesota, 55441

Boston Childrens' Hospital, Boston, Massachusetts

Status

Address

Boston Childrens' Hospital

Boston, Massachusetts, 02115

Massachusetts General Hospital, Boston, Massachusetts

Status

Address

Massachusetts General Hospital

Boston, Massachusetts, 02114

Johns Hopkins Hospital, Baltimore, Maryland

Status

Address

Johns Hopkins Hospital

Baltimore, Maryland, 21205

Normal, Illinois

Status

Address

Sneeze, Wheeze and Itch Associates,Clinical Research

Normal, Illinois, 62704

Chicago, Illinois

Status

Address

Ann & Robert H. Lurie Children's Hospital of CHicago

Chicago, Illinois, 60611

Atlanta Allergy & Asthma Clinic, Marietta, Georgia

Status

Address

Atlanta Allergy & Asthma Clinic

Marietta, Georgia, 30060

Sarasota Clinical Research, Sarasota, Florida

Status

Address

Sarasota Clinical Research

Sarasota, Florida, 34239

National Jewish Health, Denver, Colorado

Status

Address

National Jewish Health

Denver, Colorado, 80206

Children's Hospital Colorado, Aurora, Colorado

Status

Address

Children's Hospital Colorado

Aurora, Colorado, 80045

Stanford University School of Medicine, Stanford, California

Status

Address

Stanford University School of Medicine

Stanford, California, 94304

Palos Verdes Medical Group, Rolling Hills Estates, California

Status

Address

Palos Verdes Medical Group

Rolling Hills Estates, California, 90274

Mission Viejo, California

Status

Address

Allergy & Asthma Associates of Southern California

Mission Viejo, California, 92691

Arkansas Children's Hospital, Little Rock, Arkansas

Status

Address

Arkansas Children's Hospital

Little Rock, Arkansas, 72202

International Sites

Centre De Recherche Applique, Québec, Canada

Status

Address

Centre De Recherche Applique

Québec, , G1V 4W2

Montréal, Quebec, Canada

Status

Address

Centre Hospitalier Universitaire Sainte Justine

Montréal, Quebec, H3T 1C5

Gordon Sussman Clinical Research Inc., Toronto, Ontario, Canada

Status

Address

Gordon Sussman Clinical Research Inc.

Toronto, Ontario, M4V 1R2

Ottawa Allergy Asthma Research Institute, Ottawa, Ontario, Canada

Status

Address

Ottawa Allergy Asthma Research Institute

Ottawa, Ontario, K1G 6C6

Alpha Medical Research Inc., Mississauga, Ontario, Canada

Status

Address

Alpha Medical Research Inc.

Mississauga, Ontario, L5A 3V4

Vancouver, British Columbia, Canada

Status

Address

Children's and Women's Health Centre of Brisith Columbia

Vancouver, British Columbia, V6H 3N1

The content provided on clinical trials is for informational purposes only and is not a substitute for medical consultation with your healthcare provider. We do not recommend or endorse any specific study and you are advised to discuss the information shown with your healthcare provider. While we believe the information presented on this website to be accurate at the time of writing, we do not guarantee that its contents are correct, complete, or applicable to any particular individual situation. We strongly encourage individuals to seek out appropriate medical advice and treatment from their physicians. We cannot guarantee the availability of any clinical trial listed and will not be responsible if you are considered ineligible to participate in a given clinical trial. We are also not liable for any injury arising as a result of participation.